VARSITY: Vedolizumab showed superior Efficacy than that of Adalimumab in terms of clinical Remission and Mucosal Healing in Patients with moderate to severe active Ulcerative colitis

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2019年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of vedolizumab in the treatment of patients with moderate to severe Ulcerative Colitis: a systematic review and meta-analysis
    Khorshid, M.
    Alboraie, M.
    Abbas, W.
    Sayed, Z. E.
    El-Nady, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S516 - S517
  • [32] The systemic immune-inflammation index is superior to predicting clinical remission and relapse for ulcerative colitis patients treated with vedolizumab
    Yan, Jing
    Wu, Jun
    Wang, Rongkun
    Meng, Pin
    Liu, Ailing
    Xu, Yonghong
    FRONTIERS IN MEDICINE, 2025, 12
  • [33] HISTOLOGIC REMISSION AND MUCOSAL HEALING IN A PHASE 2 STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Pai, Rish
    Canavan, James
    Tuttle, Jay
    Durante, Michael
    Arora, Vipin
    Milch, Catherine
    Harpaz, Noam
    D'Haens, Geert R.
    Sands, Bruce E.
    Sandborn, William J.
    GASTROENTEROLOGY, 2020, 158 (06) : S1187 - S1187
  • [34] Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?
    Rutka, Mariann
    Milassin, Agnes
    Szepes, Zoltan
    Szucs, Monika
    Nyari, Tibor
    Balint, Anita
    Bor, Renata
    Molnar, Tamas
    Farkas, Klaudia
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (08) : 985 - 990
  • [35] Cytomegalovirus colitis in patients with moderate-to-severe Ulcerative Colitis: diagnosis, clinical impact and treatment efficacy
    Melotti, L.
    Salice, M.
    Rinaldi, M.
    Dussias, N.
    Vanigli, N.
    Scaioli, E.
    Hrustemovic, H. Privitera
    Rizzello, F.
    Gionchetti, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I567 - I568
  • [36] Comparative efficacy of vedolizumab and infliximab in patients with moderate-to-severe ulcerative colitis: a multicenter real world cohort study
    Sun, Y.
    Yang, H.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1555 - i1555
  • [37] Number Needed to Treat to Maintain Clinical Remission With Advanced Therapies in Patients With Moderate to Severe Ulcerative Colitis
    Jiang, Jeanne
    Choi, Sun
    Muller, Ben
    Tsang, Cynthia
    Wojtowicz, Abigail
    Little, Aurelia
    Ferrufino, Cheryl
    Bilir, Pinar
    Krishnamurthy, Pallavi
    Fan, Tao
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S920 - S920
  • [38] Intestinal ultrasonography predicts short term clinical remission in patients with moderate-to-severe ulcerative colitis
    Zorzi, F.
    De Cristofaro, E.
    Abreu, M. T.
    Montesano, L.
    Cuccagna, E.
    Essofi, S.
    Biancone, L.
    Monteleone, G.
    Calabrese, E.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 895 - 896
  • [39] INTESTINAL ULTRASONOGRAPHY PREDICTS SHORT TERM CLINICAL REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Zorzi, Francesca
    De Cristofaro, Elena
    Abreu, Maria T.
    Cuccagna, Elisa
    Essofi, Sara
    Biancone, Livia
    Monteleone, Giovanni
    Calabrese, Emma
    GASTROENTEROLOGY, 2023, 164 (06) : S1110 - S1110
  • [40] Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission
    Takano, Ryosuke
    Osawa, Satoshi
    Uotani, Takahiro
    Tani, Shinya
    Ishida, Natsuki
    Tamura, Satoshi
    Yamade, Mihoko
    Iwaizumi, Moriya
    Hamaya, Yasushi
    Furuta, Takahisa
    Miyajima, Hiroaki
    Sugimoto, Ken
    WORLD JOURNAL OF CLINICAL CASES, 2018, 6 (15) : 952 - 960
12345